Mina M. Rizk, MD

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York; Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York

JCP
Immune Targeted Therapies for Depression: Antidepressant Effects of Monoclonal Antibodies
Narrative Review

June 24, 2024

Immune dysregulation may contribute to treatment resistance in depression. Monoclonal antibodies have shown promise in treating depression when used for inflammatory disorders and may offer new hope for patients...
Mina M. Rizk, Lindsay Bolton, Flurin Cathomas, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe